CA
BSX icon

CSM Advisors’s Boston Scientific BSX Stock Holding History

CSM Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.74M Buy
+59,638
New +$4.77M 0.09% 249

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CSM Advisors's BSX Position: Q1 2026 in Review

CSM Advisors opened a new position in Boston Scientific (BSX) in Q1 2026: 59,638 shares worth $3.74M. The stake represents 0.09% of the portfolio and ranks #249 among its holdings.

1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • CSM Advisors held 59,638 shares of Boston Scientific worth $3.74M as of Q1 2026.
  • Boston Scientific was a new CSM Advisors position in Q1 2026.
  • Boston Scientific made up 0.09% of CSM Advisors's portfolio in Q1 2026, its #249 holding.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on CSM Advisors's 13F filing for Q1 2026, filed 15 May 2026.